MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

Search

Globus Medical Inc (Class A)

Fermé

SecteurSoins de santé

56.53 1.2

Résumé

Variation du prix de l'action

24h

Actuel

Min

55.58

Max

56.59

Chiffres clés

By Trading Economics

Revenu

49M

75M

Ventes

-59M

598M

P/E

Moyenne du Secteur

42.813

39.857

Marge bénéficiaire

12.617

Employés

5,300

EBITDA

19M

164M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+48.42% upside

Dividendes

By Dow Jones

Prochains Résultats

5 août 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-3.6B

7.8B

Ouverture précédente

55.33

Clôture précédente

56.53

Sentiment de l'Actualité

By Acuity

27%

73%

11 / 376 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

Globus Medical Inc (Class A) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

16 juil. 2025, 23:56 UTC

Acquisitions, Fusions, Rachats

Alimentation Couche-Tard Ends Bid to Buy Seven & I Holdings -- 2nd Update

16 juil. 2025, 23:43 UTC

Acquisitions, Fusions, Rachats

Santos 2Q Output Rises 1% as Takeover Campaign Continues

16 juil. 2025, 23:00 UTC

Acquisitions, Fusions, Rachats

Alimentation Couche-Tard Ends Bid to Buy Seven & I Holdings -- Update

16 juil. 2025, 22:38 UTC

Acquisitions, Fusions, Rachats

Alimentation Couche-Tard Withdraws Seven & i Acquisition Proposal

16 juil. 2025, 23:44 UTC

Market Talk

Gold Steady; Geopolitical Tensions in Middle East Support -- Market Talk

16 juil. 2025, 23:42 UTC

Market Talk

Nikkei May Fall as Yen Strengthens -- Market Talk

16 juil. 2025, 23:24 UTC

Market Talk

Australian Job Market Data to Shape RBA Calls -- Market Talk

16 juil. 2025, 23:18 UTC

Acquisitions, Fusions, Rachats

Santos Now Expects 2025 Production of 90 Million-95 Million BOE

16 juil. 2025, 23:18 UTC

Acquisitions, Fusions, Rachats

Santos Cuts Top End of 2025 Production Guidance

16 juil. 2025, 23:17 UTC

Acquisitions, Fusions, Rachats

Santos: Production Recovery Underway in Cooper Basin

16 juil. 2025, 23:17 UTC

Acquisitions, Fusions, Rachats

Santos: Over 200 Wells, Several Upstream Compressors in Cooper Basin Shut In

16 juil. 2025, 23:17 UTC

Acquisitions, Fusions, Rachats

Santos: Cooper Basin Production Impacted by Floods in 2Q

16 juil. 2025, 23:16 UTC

Acquisitions, Fusions, Rachats

Santos: Pikka Phase 1 Project in Alasia 89% Complete

16 juil. 2025, 23:16 UTC

Acquisitions, Fusions, Rachats

Santos Keeps 2025 Major Development Project Capex Guidance Unchanged

16 juil. 2025, 23:13 UTC

Acquisitions, Fusions, Rachats

Santos Had Gearing of 20.5% at End-June, Excluding Operating Leases

16 juil. 2025, 23:13 UTC

Acquisitions, Fusions, Rachats

Santos Says Moomba CCS Phase 1 Project Performing to Expectations

16 juil. 2025, 23:12 UTC

Acquisitions, Fusions, Rachats

Santos Narrows 2025 Unit Production Cost Guidance to US$7.00-US$7.40/BOE

16 juil. 2025, 23:12 UTC

Acquisitions, Fusions, Rachats

Santos 1H Free Cash Flow From Operations US$1.1 Billion

16 juil. 2025, 23:11 UTC

Acquisitions, Fusions, Rachats

Santos 2Q Free Cash Flow From Operations US$620 Million

16 juil. 2025, 23:11 UTC

Acquisitions, Fusions, Rachats

Santos 2Q Oil, Natural Gas Output 22.2 Million BOE

16 juil. 2025, 23:11 UTC

Acquisitions, Fusions, Rachats

Santos 2Q Oil, Natural Gas Sales Volumes 23.9 Million BOE

16 juil. 2025, 23:11 UTC

Acquisitions, Fusions, Rachats

Santos 2Q Oil, Natural Gas Sales Volumes Up 3% on 1Q

16 juil. 2025, 23:11 UTC

Acquisitions, Fusions, Rachats

Santos 2Q Oil, Natural Gas Output Up 1% on 1Q

16 juil. 2025, 22:43 UTC

Market Talk

Alcoa Using High Costs of More Production to Battle Tariff -- Market Talk

16 juil. 2025, 22:35 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

16 juil. 2025, 22:35 UTC

Market Talk
Résultats

Replacing Aluminum Imports With U.S. Production Not Seen Feasible -- Market Talk

16 juil. 2025, 22:33 UTC

Market Talk
Résultats

Alcoa Will Continue to Ship Aluminum Outside of the U.S. -- Market Talk

16 juil. 2025, 22:28 UTC

Market Talk
Résultats

Aluminum Price in U.S. Doesn't Offset Tariff Costs, Alcoa says -- Market Talk

16 juil. 2025, 22:22 UTC

Market Talk
Résultats

Market Talk Roundup: Latest on U.S. Politics

16 juil. 2025, 22:22 UTC

Market Talk
Résultats

Alcoa Considers Restart of Idle Capacity at Indiana Smelter -- Market Talk

Comparaison

Variation de prix

Globus Medical Inc (Class A) prévision

Objectif de Prix

By TipRanks

48.42% hausse

Prévisions sur 12 Mois

Moyen 82.92 USD  48.42%

Haut 105 USD

Bas 68 USD

Basé sur 14 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

14 ratings

8

Achat

6

Maintien

0

Vente

Score Technique

By Trading Central

72.18 / 73.07Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

11 / 376Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.